TIME TO FLARE AND GLUCOCORTICOID EXPOSURE IN PATIENTS WITH NEW-ONSET VERSUS RELAPSING GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB OR PLACEBO PLUS PREDNISONE TAPERING: 3-YEAR RESULTS FROM A RANDOMIZED CONTROLLED PHASE 3 TRIAL
Stone JH, Spotswood H, Unizony S, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J, Salvarani C, Spiera R, Bao M (2020)
Publication Type: Conference contribution
Publication year: 2020
Journal
Publisher: BMJ PUBLISHING GROUP
City/Town: LONDON
Pages Range: 20-20
Conference Proceedings Title: ANNALS OF THE RHEUMATIC DISEASES
Event location: Online
DOI: 10.1136/annrheumdis-2020-eular.1538
Authors with CRIS profile
Involved external institutions
Harvard University
United States (USA) (US)
Roche Products Limited and Roche Diagnostics Limited
United Kingdom (GB)
Technische Universität Dresden
Germany (DE)
University of Groningen / Rijksuniversiteit Groningen
Netherlands (NL)
Arcispedale Santa Maria Nuova
Italy (IT)
Southend Hospital
United Kingdom (GB)
Universitat de Barcelona (UB) / University of Barcelona
Spain (ES)
Cornell University
United States (USA) (US)
Genentech Inc.
United States (USA) (US)
University Hospital Leuven (UZ) / Universitaire ziekenhuizen Leuven
Belgium (BE)
United States (USA) (US)
Roche Products Limited and Roche Diagnostics Limited
United Kingdom (GB)
Technische Universität Dresden
Germany (DE)
University of Groningen / Rijksuniversiteit Groningen
Netherlands (NL)
Arcispedale Santa Maria Nuova
Italy (IT)
Southend Hospital
United Kingdom (GB)
Universitat de Barcelona (UB) / University of Barcelona
Spain (ES)
Cornell University
United States (USA) (US)
Genentech Inc.
United States (USA) (US)
University Hospital Leuven (UZ) / Universitaire ziekenhuizen Leuven
Belgium (BE)
How to cite
APA:
Stone, J.H., Spotswood, H., Unizony, S., Aringer, M., Blockmans, D., Brouwer, E.,... Bao, M. (2020). TIME TO FLARE AND GLUCOCORTICOID EXPOSURE IN PATIENTS WITH NEW-ONSET VERSUS RELAPSING GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB OR PLACEBO PLUS PREDNISONE TAPERING: 3-YEAR RESULTS FROM A RANDOMIZED CONTROLLED PHASE 3 TRIAL. In ANNALS OF THE RHEUMATIC DISEASES (pp. 20-20). Online: LONDON: BMJ PUBLISHING GROUP.
MLA:
Stone, J. H., et al. "TIME TO FLARE AND GLUCOCORTICOID EXPOSURE IN PATIENTS WITH NEW-ONSET VERSUS RELAPSING GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB OR PLACEBO PLUS PREDNISONE TAPERING: 3-YEAR RESULTS FROM A RANDOMIZED CONTROLLED PHASE 3 TRIAL." Proceedings of the Annual European Congress of Rheumatology (EULAR), Online LONDON: BMJ PUBLISHING GROUP, 2020. 20-20.
BibTeX: Download